Cost-effectiveness analysis of annual screening strategies for endometrial cancer

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 6, 2009, Pages 640.e1-640.e8

  Havrilesky, Laura J ^a   Maxwell, G Larry ^b,c   Myers, Evan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

cost effectiveness; endometrial cancer; serum screening

Indexed keywords

BIOLOGICAL MARKER; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG USE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED;

EID: 67349142339     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.02.022     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Bjorge T., Engeland A., Tretli S., and Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120 (2007) 378-383
3. Swerdlow A.J., and Jones M.E. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 97 (2005) 375-384
4. Yurkovetsky Z., Ta'asan S., Skates S., et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. Gynecol Oncol 107 (2007) 58-65
5. Arias E. United States life tables, 2003. Natl Vital Stat Rep 54 (2006) 1-40
6. Keshavarz H., Hillis S.D., Kieke B.A., and Marchbanks P.A. Hysterectomy surveillance-United States, 1994-1999. MMWR Morb Mortal Wkly Rep 51 (2002) 1-8
7. Wingo P.A., Huezo C.M., Rubin G.L., Ory H.W., and Peterson H.B. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 152 (1985) 803-808
8. State specific prevalence of obesity among adults-United States 2005. MMWR 55 (2006) 985-988
9. Hurley S.F., and Matthews J.P. The quit benefits model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Alloc 5 (2007) 2
10. Bernstein L., Deapen D., Cerhan J.R., et al. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91 (1999) 1654-1662
11. Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J., and van Leeuwen F.E. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 356 (2000) 881-887
12. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348 (2003) 1625-1638
13. Eddy D.M. Screening for cervical cancer. Ann Intern Med 113 (1990) 214-226
14. Fletcher S.W. Whither scientific deliberation in health policy recommendations?. Alice in the Wonderland of breast-cancer screening. N Engl J Med 336 (1997) 1180-1183
15. Ubel P.A., Hirth R.A., Chernew M.E., and Fendrick A.M. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 163 (2003) 1637-1641
16. Clark T.J., Barton P.M., Coomarasamy A., Gupta J.K., and Khan K.S. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG 113 (2006) 502-510
17. Smith-Bindman R., Weiss E., and Feldstein V. How thick is too thick?. When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol 24 (2004) 558-565
18. Clark T.J., Mann C.H., Shah N., Khan K.S., Song F., and Gupta J.K. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 109 (2002) 313-321
19. Gupta JK Chien P.F., Voit D., Clark T.J., and Khan K.S. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 81 (2002) 799-816